BACKGROUND:α(2A)-Adrenoceptors (α(2A)-ARs) have important roles in sympathetic cardiovascular regulation. Variants of ADRA2A affect gene transcription and expression and are associated with insulin release and risk for type 2 diabetes. We examined whether ADRA2A variants are also associated with cardiovascular responses to the selective α(2)-AR-agonist dexmedetomidine. METHODS AND RESULTS:Seventy-three healthy subjects participated in aplacebo-controlled, single-blind study. After 3 infusions of placebo, subjects received 3 incremental infusions of dexmedetomidine (cumulative dose, 0.4 μg/kg). Primary outcomes were changes in systolic blood pressure (SBP) and plasma norepinephrine concentrations, measured as difference of the area-under-the-curve during placebo and dexmedetomidine infusions (ΔAUC). We used multiple linear regression analysis to examine the associations between 9 ADRA2A tagging variants and 5 inferred haplotypes and ΔAUC after adjustment for covariates. Homozygous carriers of rs553668 and the corresponding haplotype 4, previously associated with increased α(2A)-AR expression, had a 2.2-fold greater decrease in AUC(SBP) after dexmedetomidine (adjusted P=0.006); similarly, the maximum decrease in SBP was 24.7±8.1 mm Hg compared with 13.6±5.9 mm Hg in carriers of the wild-type allele (P=0.007). Carriers of haplotype 3, previously associated with reduced α(2A)-AR expression, had a 44% smaller decrease in AUC(SBP) (P=0.013). Haplotype information significantly improved the model predicting the decrease in SBP (P<0.001). There were similar but nonsignificant trends for diastolic blood pressure and heart rate. Genotypes were not significantly associated with norepinephrine responses. CONCLUSIONS: Common ADRA2A variants are associated with the hypotensive response to dexmedetomidine. Effects of specific variants/haplotypes in vivo are compatible with their known effects on gene expression in vitro.
RCT Entities:
BACKGROUND: α(2A)-Adrenoceptors (α(2A)-ARs) have important roles in sympathetic cardiovascular regulation. Variants of ADRA2A affect gene transcription and expression and are associated with insulin release and risk for type 2 diabetes. We examined whether ADRA2A variants are also associated with cardiovascular responses to the selective α(2)-AR-agonist dexmedetomidine. METHODS AND RESULTS: Seventy-three healthy subjects participated in a placebo-controlled, single-blind study. After 3 infusions of placebo, subjects received 3 incremental infusions of dexmedetomidine (cumulative dose, 0.4 μg/kg). Primary outcomes were changes in systolic blood pressure (SBP) and plasma norepinephrine concentrations, measured as difference of the area-under-the-curve during placebo and dexmedetomidine infusions (ΔAUC). We used multiple linear regression analysis to examine the associations between 9 ADRA2A tagging variants and 5 inferred haplotypes and ΔAUC after adjustment for covariates. Homozygous carriers of rs553668 and the corresponding haplotype 4, previously associated with increased α(2A)-AR expression, had a 2.2-fold greater decrease in AUC(SBP) after dexmedetomidine (adjusted P=0.006); similarly, the maximum decrease in SBP was 24.7±8.1 mm Hg compared with 13.6±5.9 mm Hg in carriers of the wild-type allele (P=0.007). Carriers of haplotype 3, previously associated with reduced α(2A)-AR expression, had a 44% smaller decrease in AUC(SBP) (P=0.013). Haplotype information significantly improved the model predicting the decrease in SBP (P<0.001). There were similar but nonsignificant trends for diastolic blood pressure and heart rate. Genotypes were not significantly associated with norepinephrine responses. CONCLUSIONS: Common ADRA2A variants are associated with the hypotensive response to dexmedetomidine. Effects of specific variants/haplotypes in vivo are compatible with their known effects on gene expression in vitro.
Authors: Jia-Ling Li; Russell M Canham; Wanpen Vongpatanasin; David Leonard; Richard J Auchus; Ronald G Victor Journal: Hypertension Date: 2006-04-24 Impact factor: 10.190
Authors: Kersten M Small; Kari M Brown; Carrie A Seman; Cheryl T Theiss; Stephen B Liggett Journal: Proc Natl Acad Sci U S A Date: 2006-03-27 Impact factor: 11.205
Authors: J D Altman; A U Trendelenburg; L MacMillan; D Bernstein; L Limbird; K Starke; B K Kobilka; L Hein Journal: Mol Pharmacol Date: 1999-07 Impact factor: 4.436
Authors: Utkarsh Kohli; Mordechai Muszkat; Gbenga G Sofowora; Paul A Harris; Eitan A Friedman; William D Dupont; Mika Scheinin; Alastair J J Wood; C Michael Stein; Daniel Kurnik Journal: Eur J Pain Date: 2009-05-06 Impact factor: 3.931
Authors: Daniel Kurnik; Mordechai Muszkat; Chun Li; Gbenga G Sofowora; Joseph Solus; Hong-Guang Xie; Paul A Harris; Lan Jiang; Chara McMunn; Patrick Ihrie; Elliott P Dawson; Scott M Williams; Alastair J J Wood; C Michael Stein Journal: Clin Pharmacol Ther Date: 2006-02-07 Impact factor: 6.875
Authors: Abiodun Adefurin; Leon Darghosian; Chimalum Okafor; Vivian Kawai; Chun Li; Anushi Shah; Wei-Qi Wei; Daniel Kurnik; C Michael Stein Journal: Int J Cardiol Date: 2016-04-13 Impact factor: 4.164
Authors: Laxmi V Ghimire; Mordechai Muszkat; Gbenga G Sofowora; Mika Scheinin; Alastair J J Wood; C Michael Stein; Daniel Kurnik Journal: Pharmacogenet Genomics Date: 2013-09 Impact factor: 2.089
Authors: Sara L Van Driest; Lynn A Sleeper; Bruce D Gelb; Shaine A Morris; Harry C Dietz; Geoffrey A Forbus; Elizabeth Goldmuntz; Arvind Hoskoppal; Jeanne James; Teresa M Lee; Jami C Levine; Jennifer S Li; Bart L Loeys; Larry W Markham; Josephina A N Meester; Seema Mital; Jonathan D Mosley; Aaron K Olson; Marjolijn Renard; Christian M Shaffer; Angela Sharkey; Luciana Young; Ronald V Lacro; Dan M Roden Journal: J Pediatr Date: 2020-07 Impact factor: 4.406
Authors: Rafael Amorim Belo Nunes; Lucia Pereira Barroso; Alexandre da Costa Pereira; Maria Urbana Pinto Brandão Rondon; Carlos Eduardo Negrão; José Eduardo Krieger; Alfredo José Mansur Journal: Int J Cardiol Heart Vasc Date: 2016-10-13
Authors: Samantha F Holliday; Sandra L Kane-Gill; Philip E Empey; Mitchell S Buckley; Pamela L Smithburger Journal: ScientificWorldJournal Date: 2014-01-16